Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period

Hellenic Journal of Cardiology

Volumn 50, Issue 4, 2009, Pages 269-274

  Papadopoulou, Evangelia F ^a   Mavrogeni, Sophie I ^a   Dritsas, Athanasios ^a   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Heart failure; Left ventricular dysfunction 36 (LVD 36); Minnesota living with heart failure questionnaire (LIhFE); Specific activity questionnaire (SAQ)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LEVOSIMENDAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG INTERMITTENT THERAPY; ECHOCARDIOGRAPHY; FEMALE; GENERAL CONDITION IMPROVEMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; PHYSICAL STRESS; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYDRAZONES; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIDAZINES; QUALITY OF LIFE; QUESTIONNAIRES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 67749122523     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Willenheimer R. We need nurse-based heart failure clinics. Scand Cardiovasc J. 2005; 39: 197-198.
2. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000; 83: 596-602.
3. McCullough P, Philbin E, Speretus J, Kaatz S, Sandberg K, Weawer D. Confirmation of a heart failure epidemic: findings from the Resource Utilisation Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol. 2002; 39: 60-69.
4. Parajón T, Lupón J, Gonzalez B, et al. Use of the "Minnesota Living With Heart Failure" Quality of Life Questionnaire in Spain. Rev Esp Cardiol. 2004; 57: 155-160.
5. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J. 1998; 19 (Suppl P): 9-12.
6. Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as predictor of mortality and hospitalisation in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies Of Left Ventricular Dysfunction Investigators. Am J Cardiol. 1996; 78: 890-895.
7. Hulsmann M, Berger R, Sturm B, et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J. 2002; 23: 886-891.
8. Rogers WJ, Johnstone DE, Yusurf S, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomised between placebo and enalapril: the Studies Of Left Ventricular Dysfunction. The SOLVD Investigators. J Am Coll Cardiol. 1994; 23: 393-400.
9. Alta F, Briancon S, Guillemin F, et al; for the EPICAL investigators. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail. 2002; 4: 337-343.
10. Rankin SL, Briffa TG, Morton AR, Hung J. A specific activity questionnaire to measure the functional capacity of cardiac patients. Am J Cardiol. 1996; 77: 1220-1223.
11. O'Leary CJ, Jones PW. The left ventricular dysfunction questionnaire (LVD 36): reliability, validity, and responsiveness. Heart. 2000; 83: 634-640.
12. Chryssanthopoulos S, Dritsas A, Cokkinos D. Activity questionnaires; a useful tool in accessing heart failure patients. Int J Cardiol. 2005; 105: 294-299.
13. Spiraki C, Kaitelidou D, Papakonstantinou V, Prezerakos P, Maniadakis N. Health-related quality of life measurement in patients admitted with coronary heart disease and heart failure to a cardiology department of a secondary urban hospital in Greece. Hellenic J Cardiol. 2008; 49: 241-247.
14. Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Hellenic J Cardiol. 2007; 48: 80-88.
15. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV. Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function. Hellenic J Cardiol. 2008; 49: 26-32.
16. Kremastinos DT. Anaemia in chronic heart failure: is there a rationale to treat? Hellenic J Cardiol. 2007; 48: 249-250.